Literature DB >> 2958105

Plasma atrial natriuretic peptide in essential hypertension: effects of changes in dietary sodium.

G A Sagnella1, N D Markandu, M G Buckley, D R Singer, A L Sugden, A C Shore, G A MacGregor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2958105      PMCID： PMC1247277          DOI： 10.1136/bmj.295.6595.417

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Plasma atrial natriuretic peptide: its relationship to changes in sodium intake, plasma renin activity and aldosterone in man.

Authors:  G A Sagnella; N D Markandu; A C Shore; M L Forsling; G A MacGregor
Journal:  Clin Sci (Lond)       Date:  1987-01       Impact factor: 6.124

2.  Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin.

Authors:  F P Cappuccio; N D Markandu; G A Sagnella; G A MacGregor
Journal:  J Hypertens       Date:  1985-06       Impact factor: 4.844

3.  Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man.

Authors:  J V Anderson; J Donckier; N N Payne; J Beacham; J D Slater; S R Bloom
Journal:  Clin Sci (Lond)       Date:  1987-03       Impact factor: 6.124

4.  The vasodilator potency of atrial natriuretic peptide in man.

Authors:  P Bolli; F B Müller; L Linder; A E Raine; T J Resink; P Erne; W Kiowski; R Ritz; F R Bühler
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.